Boothbay Fund Management’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,203
| Closed | -$70K | – | 1881 |
|
|
2023
Q2 | $70K | Hold |
1,203
| – | – | ﹤0.01% | 1428 |
|
|
2023
Q1 | $31.4K | Hold |
1,203
| – | – | ﹤0.01% | 1792 |
|
|
2022
Q4 | $35.8K | Sell |
1,203
-756
| -39% | -$22.5K | ﹤0.01% | 1652 |
|
|
2022
Q3 | $100K | Sell |
1,959
-4,040
| -67% | -$206K | ﹤0.01% | 1749 |
|
|
2022
Q2 | $174K | Buy |
5,999
+1,300
| +28% | +$37.7K | ﹤0.01% | 1555 |
|
|
2022
Q1 | $247K | Sell |
4,699
-3,253
| -41% | -$171K | 0.01% | 1378 |
|
|
2021
Q4 | $546K | Sell |
7,952
-967
| -11% | -$66.4K | 0.01% | 843 |
|
|
2021
Q3 | $1.42M | Sell |
8,919
-2,021
| -18% | -$321K | 0.04% | 480 |
|
|
2021
Q2 | $2.13M | Buy |
10,940
+655
| +6% | +$128K | 0.07% | 304 |
|
|
2021
Q1 | $2.66M | Buy |
10,285
+7,373
| +253% | +$1.9M | 0.1% | 178 |
|
|
2020
Q4 | $562K | Buy |
2,912
+353
| +14% | +$68.1K | 0.02% | 580 |
|
|
2020
Q3 | $520K | Buy |
+2,559
| New | +$520K | 0.03% | 534 |
|
|
2020
Q1 | – | Sell |
-528
| Closed | -$169K | – | 994 |
|
|
2019
Q4 | $169K | Buy |
+528
| New | +$169K | 0.01% | 624 |
|